Psychotic disorders in late life: a narrative review
Psychotic disorders are not uncommon in late life. These disorders often have varied etiologies, different clinical presentations, and are associated with significant morbidity and mortality among the older adult population. Psychotic disorders in late life develop due to the complex interaction bet...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-10-01
|
Series: | Therapeutic Advances in Psychopharmacology |
Online Access: | https://doi.org/10.1177/2045125319882798 |
id |
doaj-17d5cf0aaa2344458999b345de5d4dc8 |
---|---|
record_format |
Article |
spelling |
doaj-17d5cf0aaa2344458999b345de5d4dc82020-11-25T03:16:19ZengSAGE PublishingTherapeutic Advances in Psychopharmacology2045-12612019-10-01910.1177/2045125319882798Psychotic disorders in late life: a narrative reviewRajesh R. TampiJuan YoungRakin HoqKyle ResnickDeena J. TampiPsychotic disorders are not uncommon in late life. These disorders often have varied etiologies, different clinical presentations, and are associated with significant morbidity and mortality among the older adult population. Psychotic disorders in late life develop due to the complex interaction between various biological, psychological, social, and environmental factors. Given the significant morbidity and mortality associated with psychotic disorders in late life, a comprehensive work-up should be conducted when they are encountered. The assessment should not only identify the potential etiologies for the psychotic disorders, but also recognize factors that predicts possible outcomes for these disorders. Treatment approaches for psychotic disorders in late life should include a combination of nonpharmacological management strategies with the judicious use of psychotropic medications. When antipsychotic medications are necessary, they should be used cautiously with the goal of optimizing outcomes with regular monitoring of their efficacy and adverse effects.https://doi.org/10.1177/2045125319882798 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Rajesh R. Tampi Juan Young Rakin Hoq Kyle Resnick Deena J. Tampi |
spellingShingle |
Rajesh R. Tampi Juan Young Rakin Hoq Kyle Resnick Deena J. Tampi Psychotic disorders in late life: a narrative review Therapeutic Advances in Psychopharmacology |
author_facet |
Rajesh R. Tampi Juan Young Rakin Hoq Kyle Resnick Deena J. Tampi |
author_sort |
Rajesh R. Tampi |
title |
Psychotic disorders in late life: a narrative review |
title_short |
Psychotic disorders in late life: a narrative review |
title_full |
Psychotic disorders in late life: a narrative review |
title_fullStr |
Psychotic disorders in late life: a narrative review |
title_full_unstemmed |
Psychotic disorders in late life: a narrative review |
title_sort |
psychotic disorders in late life: a narrative review |
publisher |
SAGE Publishing |
series |
Therapeutic Advances in Psychopharmacology |
issn |
2045-1261 |
publishDate |
2019-10-01 |
description |
Psychotic disorders are not uncommon in late life. These disorders often have varied etiologies, different clinical presentations, and are associated with significant morbidity and mortality among the older adult population. Psychotic disorders in late life develop due to the complex interaction between various biological, psychological, social, and environmental factors. Given the significant morbidity and mortality associated with psychotic disorders in late life, a comprehensive work-up should be conducted when they are encountered. The assessment should not only identify the potential etiologies for the psychotic disorders, but also recognize factors that predicts possible outcomes for these disorders. Treatment approaches for psychotic disorders in late life should include a combination of nonpharmacological management strategies with the judicious use of psychotropic medications. When antipsychotic medications are necessary, they should be used cautiously with the goal of optimizing outcomes with regular monitoring of their efficacy and adverse effects. |
url |
https://doi.org/10.1177/2045125319882798 |
work_keys_str_mv |
AT rajeshrtampi psychoticdisordersinlatelifeanarrativereview AT juanyoung psychoticdisordersinlatelifeanarrativereview AT rakinhoq psychoticdisordersinlatelifeanarrativereview AT kyleresnick psychoticdisordersinlatelifeanarrativereview AT deenajtampi psychoticdisordersinlatelifeanarrativereview |
_version_ |
1724636930242510848 |